A Novel Glycosyltransferase-Related Gene Signature for Overall Survival Prediction in Patients with Ovarian Cancer

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7–33. doi:10.3322/caac.21654
   PubMed Web of Science ®Google Scholar
• Wright JD, Shah M, Mathew L, et al. Fertility preservation in young women with epithelial ovarian cancer. Cancer. 2009;115:4118–4126. doi:10.1002/cncr.24461
   PubMed Web of Science ®Google Scholar
• Feng H, Gu Z-Y, Li Q, Liu QH, Yang XY, Zhang JJ. Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis. J Ovarian Res. 2019;12(1):35. doi:10.1186/s13048-019-0508-2
   PubMed Web of Science ®Google Scholar
• Zheng MJ, Li X, Hu YX, et al. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments. J Cell Physiol. 2019;234:11023–11036. doi:10.1002/jcp.27926
   PubMed Web of Science ®Google Scholar
• Ohtsubo K, Marth JD. Glycosylation in cellular mechanisms of health and disease. Cell. 2006;126:855–867. doi:10.1016/j.cell.2006.08.019
   PubMed Web of Science ®Google Scholar
• Champattanachai V, Netsirisawan P, Chaiyawat P, et al. Proteomic analysis and abrogated expression of O-GlcNAcylated proteins associated with primary breast cancer. Proteomics. 2013;13:2088–2099. doi:10.1002/pmic.201200126
   PubMed Web of Science ®Google Scholar
• Lynch TP, Reginato MJ. O-GlcNAc transferase: a sweet new cancer target. Cell Cycle. 2011;10:1712–1713. doi:10.4161/cc.10.11.15561
   PubMed Web of Science ®Google Scholar
• Slawson C, Hart GW. O-GlcNAc signalling: implications for cancer cell biology. Nat Rev Cancer. 2011;11:678–684. doi:10.1038/nrc3114
   PubMed Web of Science ®Google Scholar
• Gu Y, Mi W, Ge Y, et al. GlcNAcylation plays an essential role in breast cancer metastasis. Cancer Res. 2010;70:6344–6351. doi:10.1158/0008-5472.CAN-09-1887
   PubMed Web of Science ®Google Scholar
• Krześlak A, Forma E, Bernaciak M, Romanowicz H, Bryś M. Gene expression of O-GlcNAc cycling enzymes in human breast cancers. Clin Exp Med. 2012;12:61–65. doi:10.1007/s10238-011-0138-5
   PubMed Web of Science ®Google Scholar
• Phueaouan T, Chaiyawat P, Netsirisawan P, et al. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer. Oncol Rep. 2013;30:2929–2936. doi:10.3892/or.2013.2794
   PubMed Web of Science ®Google Scholar
• Ruan HB, Ma Y, Torres S, et al. Calcium-dependent O-GlcNAc signaling drives liver autophagy in adaptation to starvation. Genes Dev. 2017;31:1655–1665. doi:10.1101/gad.305441.117
   PubMed Web of Science ®Google Scholar
• Skorobogatko YV, Deuso J, Adolf-Bryfogle J, et al. Human Alzheimer’s disease synaptic O-GlcNAc site mapping and iTRAQ expression proteomics with ion trap mass spectrometry. Amino Acids. 2011;40:765–779. doi:10.1007/s00726-010-0645-9
   PubMed Web of Science ®Google Scholar
• Smet-Nocca C, Broncel M, Wieruszeski JM, et al. Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation. Mol Biosyst. 2011;7:1420–1429. doi:10.1039/c0mb00337a
   PubMedGoogle Scholar
• DeBerardinis RJ, Thompson CB. Cellular metabolism and disease: what do metabolic outliers teach us? Cell. 2012;148:1132–1144. doi:10.1016/j.cell.2012.02.032
   PubMed Web of Science ®Google Scholar
• Galhardo M, Sinkkonen L, Berninger P, Lin J, Sauter T, Heinäniemi M. Integrated analysis of transcript-level regulation of metabolism reveals disease-relevant nodes of the human metabolic network. Nucleic Acids Res. 2014;42:1474–1496. doi:10.1093/nar/gkt989
   PubMed Web of Science ®Google Scholar
• Chou CH, Huang MJ, Liao YY, Chen CH, Huang MC. C1GALT1 seems to promote in vitro disease progression in ovarian cancer. Int j Gynecol Cancer. 2017;27:863–871. doi:10.1097/IGC.0000000000000965
   PubMed Web of Science ®Google Scholar
• Schultz MJ, Holdbrooks AT, Chakraborty A, et al. The tumor-associated glycosyltransferase ST6Gal-I regulates stem cell transcription factors and confers a cancer stem cell phenotype. Cancer Res. 2016;76:3978–3988. doi:10.1158/0008-5472.CAN-15-2834
   PubMed Web of Science ®Google Scholar
• Ashkani J, Naidoo KJ. Glycosyltransferase gene expression profiles classify cancer types and propose prognostic subtypes. Sci Rep. 2016;6:26451. doi:10.1038/srep26451
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16:284–287. doi:10.1089/omi.2011.0118
   PubMed Web of Science ®Google Scholar
• Aravind SB, Pablo T, Vamsi KM, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Yoshihara K, Shahmoradgoli M, Martínez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:1–11. doi:10.1038/ncomms3612
   Web of Science ®Google Scholar
• Kang SJ, Cho YR, Park GM, et al. Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging. JACC Cardiovasc Imaging. 2013;6:1183–1190. doi:10.1016/j.jcmg.2013.09.006
   PubMed Web of Science ®Google Scholar
• Varki A, Cummings RD, Esko JD; Essentials of Glycobiology, et al. Cold Spring Harbor Laboratory Press Copyright © 2009, the Consortium of Glycobiology Editors. La Jolla, California.: Cold Spring Harbor (NY);2009.
   Google Scholar
• Stowell SR, Ju T, Cummings RD. Protein glycosylation in cancer. Annu Rev Pathol. 2015;10:473–510. doi:10.1146/annurev-pathol-012414-040438
   PubMed Web of Science ®Google Scholar
• Allam H, Johnson BP, Zhang M, Lu Z, Cannon MJ, Abbott KL. The glycosyltransferase GnT-III activates Notch signaling and drives stem cell expansion to promote the growth and invasion of ovarian cancer. J Biol Chem. 2017;292:16351–16359. doi:10.1074/jbc.M117.783936
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang Y, Qian Y, et al. Discovery of specific metastasis-related N-glycan alterations in epithelial ovarian cancer based on quantitative glycomics. PLoS One. 2014;9:e87978. doi:10.1371/journal.pone.0087978
   PubMed Web of Science ®Google Scholar
• Noda K, Miyoshi E, Uozumi N, et al. Gene expression of alpha1-6 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of alpha-fetoprotein. Hepatology. 1998;28:944–952. doi:10.1002/hep.510280408
   PubMed Web of Science ®Google Scholar
• Abbott KL, Nairn AV, Hall EM, et al. Focused glycomic analysis of the N-linked glycan biosynthetic pathway in ovarian cancer. Proteomics. 2008;8:3210–3220. doi:10.1002/pmic.200800157
   PubMed Web of Science ®Google Scholar
• Ito Y, Miyauchi A, Yoshida H, et al. Expression of alpha1,6-fucosyltransferase (FUT8) in papillary carcinoma of the thyroid: its linkage to biological aggressiveness and anaplastic transformation. Cancer Lett. 2003;200:167–172. doi:10.1016/S0304-3835(03)00383-5
   PubMed Web of Science ®Google Scholar
• Muinelo-Romay L, Vázquez-Martín C, Villar-Portela S, Cuevas E, Gil-Martín E, Fernández-Briera A. Expression and enzyme activity of alpha(1,6)fucosyltransferase in human colorectal cancer. Int j Cancer. 2008;123:641–646. doi:10.1002/ijc.23521
   PubMed Web of Science ®Google Scholar
• Ishida S, Lee J, Thiele DJ, Herskowitz I. Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc Natl Acad Sci U S A. 2002;99:14298–14302. doi:10.1073/pnas.162491399
   PubMed Web of Science ®Google Scholar
• Van den Steen P, Rudd PM, Dwek RA, Opdenakker G. Concepts and principles of O-linked glycosylation. Crit Rev Biochem Mol Biol. 1998;33:151–208. doi:10.1080/10409239891204198
   PubMed Web of Science ®Google Scholar
• Nguyen TT, Kurita T, Koi C, et al. GalNAc-T6 in the relationship with invasion ability of endometrial carcinomas and prognostic significance. Am J Cancer Res. 2017;7:1188–1197.
   PubMed Web of Science ®Google Scholar
• Freire T, Berois N, Sóñora C, Varangot M, Barrios E, Osinaga E. UDP-N-acetyl-D-galactosamine:polypeptideN-acetylgalactosaminyltransferase 6 (ppGalNAc-T6) mRNA as a potential new marker for detection of bone marrow-disseminated breast cancer cells. Int j Cancer. 2006;119:1383–1388. doi:10.1002/ijc.21959
   PubMed Web of Science ®Google Scholar
• Berois N, Mazal D, Ubillos L, et al. UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker. j Histochem Cytochemistry. 2006;54:317–328. doi:10.1369/jhc.5A6783.2005
   PubMed Web of Science ®Google Scholar
• Yang R, Zhang H, Ma Y, et al. The role of ppGalNAc-T family in breast cancer development and progression. Indian J Cancer. 2015;52(Suppl 3):E144–147. doi:10.4103/0019-509X.186556
   PubMed Web of Science ®Google Scholar
• Tarhan YE, Kato T, Jang M, et al. Morphological changes, cadherin switching, and growth suppression in pancreatic cancer by GALNT6 knockdown. Neoplasia. 2016;18:265–272. doi:10.1016/j.neo.2016.03.005
   PubMed Web of Science ®Google Scholar
• Duan J, Chen L, Gao H, et al. GALNT6 suppresses progression of colorectal cancer. Am J Cancer Res. 2018;8:2419–2435.
   PubMed Web of Science ®Google Scholar
• Lin TC, Chen ST, Huang MC, et al. GALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity. Oncotarget. 2017;8:42588–42601. doi:10.18632/oncotarget.16585
   PubMedGoogle Scholar
• Ren F, Wang DB, Li T, Chen YH, Li Y. Identification of differentially methylated genes in the malignant transformation of ovarian endometriosis. J Ovarian Res. 2014;7:73. doi:10.1186/1757-2215-7-73
   PubMed Web of Science ®Google Scholar
• Jacob F, Hitchins MP, Fedier A, et al. Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells. BMC Mol Biol. 2014;15:24. doi:10.1186/1471-2199-15-24
   PubMed Web of Science ®Google Scholar
• Gao L, Zhang H, Zhang B, Zhu J, Chen C, Liu W. B3GNT3 overexpression is associated with unfavourable survival in non-small cell lung cancer. J Clin Pathol. 2018;71:642–647. doi:10.1136/jclinpath-2017-204860
   PubMed Web of Science ®Google Scholar
• Zhang W, Hou T, Niu C, Song L, Zhang Y. B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer. PLoS One. 2015;10:e0144360. doi:10.1371/journal.pone.0144360
   PubMed Web of Science ®Google Scholar
• Sun H, Chang J, Ye M, et al. GCNT4 is Associated with Prognosis and Suppress Cell Proliferation in Gastric Cancer. Onco Targets Ther. 2020;13:8601–8613. doi:10.2147/OTT.S248997
   PubMed Web of Science ®Google Scholar
• Huang HC, Chao CC, Wu PH, et al. Epigenetic silencing of the synthesis of immunosuppressive Siglec ligand glycans by NF-κB/EZH2/YY1 axis in early-stage colon cancers. Gene Regulatory Mechanisms. 2019;1862:173–183. doi:10.1016/j.bbagrm.2019.01.002
   Web of Science ®Google Scholar
• Manos EJ, Kim ML, Kassis J, Chang PY, Wells A, Jones DA. Dolichol-phosphate-mannose-3 (DPM3)/prostin-1 is a novel phospholipase C-gamma regulated gene negatively associated with prostate tumor invasion. Oncogene. 2001;20:2781–2790. doi:10.1038/sj.onc.1204379
   PubMed Web of Science ®Google Scholar
• Tang W, Li M, Qi X, Li J. β1,4-Galactosyltransferase V Modulates Breast Cancer Stem Cells through Wnt/β-catenin Signaling Pathway. Cancer Res Treatment. 2020;52:1084–1102.
   Google Scholar
• Wang D, Zhu ZZ, Jiang H, et al. Multiple genes identified as targets for 20q13.12-13.33 gain contributing to unfavorable clinical outcomes in patients with hepatocellular carcinoma. Hepatol Int. 2015;9:438–446. doi:10.1007/s12072-015-9642-0
   PubMed Web of Science ®Google Scholar
• Murugaesu N, Iravani M, van Weverwijk A, et al. An in vivo functional screen identifies ST6GalNAc2 sialyltransferase as a breast cancer metastasis suppressor. Cancer Discov. 2014;4:304–317. doi:10.1158/2159-8290.CD-13-0287
   PubMed Web of Science ®Google Scholar
• Jia L, Luo S, Ren X, et al. miR-182 and miR-135b Mediate the Tumorigenesis and Invasiveness of Colorectal Cancer Cells via Targeting ST6GALNAC2 and PI3K/AKT Pathway. Dig Dis Sci. 2017;62:3447–3459. doi:10.1007/s10620-017-4755-z
   PubMed Web of Science ®Google Scholar
• Cao Q, Chen X, Wu X, et al. Inhibition of UGT8 suppresses basal-like breast cancer progression by attenuating sulfatide-αVβ5 axis. J Exp Med. 2018;215:1679–1692. doi:10.1084/jem.20172048
   PubMed Web of Science ®Google Scholar
• Dzięgiel P, Owczarek T, Plazuk E, et al. Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases. Br J Cancer. 2010;103:524–531. doi:10.1038/sj.bjc.6605750
   PubMed Web of Science ®Google Scholar
• Gao P, Wang F, Huo J, et al. ALG13 Deficiency Associated with Increased Seizure Susceptibility and Severity. Neuroscience. 2019;409:204–221. doi:10.1016/j.neuroscience.2019.03.009
   PubMed Web of Science ®Google Scholar
• Bulc M, Całka J, Meller K, Jana B. Endometritis affects chemical coding of the dorsal root ganglia neurons supplying uterus in the sexually mature gilts. Res Vet Sci. 2019;124:417–425. doi:10.1016/j.rvsc.2019.05.003
   PubMed Web of Science ®Google Scholar
• Hennet T, Cabalzar J. Congenital disorders of glycosylation: a concise chart of glycocalyx dysfunction. Trends Biochem Sci. 2015;40:377–384. doi:10.1016/j.tibs.2015.03.002
   PubMed Web of Science ®Google Scholar
• Besse W, Dong K, Choi J, et al. Isolated polycystic liver disease genes define effectors of polycystin-1 function. J Clin Invest. 2017;127:1772–1785. doi:10.1172/JCI90129
   PubMed Web of Science ®Google Scholar
• Anderson S. GALT Deficiency Galactosemia. MCN. Am j Maternal Child Nursing. 2018;43:44–51. doi:10.1097/NMC.0000000000000388
   PubMed Web of Science ®Google Scholar
• Klebanoff CA, Gattinoni L, Restifo NP. Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy? J Immunother. 2012;35:651–660. doi:10.1097/CJI.0b013e31827806e6
   PubMed Web of Science ®Google Scholar
• Klebanoff CA, Gattinoni L, Torabi-Parizi P, et al. Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci U S A. 2005;102:9571–9576. doi:10.1073/pnas.0503726102
   PubMed Web of Science ®Google Scholar